Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O M Moiseeva

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Terapevticheskii Arkhiv|June 30, 2020
[Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension]M A Simakova, A V Ryzhkov, A V Kazymly, et al.
Klinicheskaia Laboratornaia Diagnostika|September 29, 2019
[The metabolic and protein markers of dysfunction of mitochondria in patients with cardio-vascular diseases.]A A Zhloba, T F Subbotina, E S Alekseevskaia, et al.
Terapevticheskii Arkhiv|October 24, 2012
[Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases]O M Moiseeva, L B Mitrofanova, E V Nakatseva, et al.
Tsitologiia|January 1, 1997
[Comparative study of the level of cardiomyocyte hypertrophy in patients suffering from ischemic heart disease with normal arterial pressure and in hypertension]G V Selivanova, T D Vlasova, O M Moiseeva, et al.
Kardiologiia|March 16, 2017
[Value of Two Dimensional Echocardiography for Assessment of Disease Severity in Patients With Pulmonary Hypertension]A V Kyzymly, A V Ryzhkov, M A Simakova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|April 23, 2004
[Heat shock proteins 70 kD as a new marker of lesions to target organs in hypertension]O M Moiseeva, S S Novoselov, E A Liasnikova, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|December 18, 2015
[MODIFICATION OF MESENCHYMAL STEM CELLS AS A WAY TO IMPROVE THE EFFECTIVENESS OF CELL THERAPY OF ISCHEMIC MYOCARDIAL INJURY]A A Karpov, A V Drahova, D V Buslova, et al.
Biomeditsinskaia Khimiia|May 5, 2016
[The level of circulating PGC1a in cardiovascular disease]A A Zhloba, T F Subbotina, E S Alekseevskaya, et al.
Kardiologiia|September 10, 2025
[Early Myocardial Calcification on the Background of Fulminant Lymphocytic-Macrophage Myocarditis]S V Mayrina, I A Makarov, K B Lapshin, et al.
Kardiologiia|February 22, 2018
[Interventional treatment in patients with myocarditis: Pro and Contra]V A Syrovnev, D S Lebedev, L B Mitrofanova, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Terapevticheskii Arkhiv|June 30, 2020
[Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension]M A Simakova, A V Ryzhkov, A V Kazymly, et al.
Klinicheskaia Laboratornaia Diagnostika|September 29, 2019
[The metabolic and protein markers of dysfunction of mitochondria in patients with cardio-vascular diseases.]A A Zhloba, T F Subbotina, E S Alekseevskaia, et al.
Terapevticheskii Arkhiv|October 24, 2012
[Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases]O M Moiseeva, L B Mitrofanova, E V Nakatseva, et al.
Tsitologiia|January 1, 1997
[Comparative study of the level of cardiomyocyte hypertrophy in patients suffering from ischemic heart disease with normal arterial pressure and in hypertension]G V Selivanova, T D Vlasova, O M Moiseeva, et al.
Kardiologiia|March 16, 2017
[Value of Two Dimensional Echocardiography for Assessment of Disease Severity in Patients With Pulmonary Hypertension]A V Kyzymly, A V Ryzhkov, M A Simakova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|April 23, 2004
[Heat shock proteins 70 kD as a new marker of lesions to target organs in hypertension]O M Moiseeva, S S Novoselov, E A Liasnikova, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|December 18, 2015
[MODIFICATION OF MESENCHYMAL STEM CELLS AS A WAY TO IMPROVE THE EFFECTIVENESS OF CELL THERAPY OF ISCHEMIC MYOCARDIAL INJURY]A A Karpov, A V Drahova, D V Buslova, et al.
Biomeditsinskaia Khimiia|May 5, 2016
[The level of circulating PGC1a in cardiovascular disease]A A Zhloba, T F Subbotina, E S Alekseevskaya, et al.
Kardiologiia|September 10, 2025
[Early Myocardial Calcification on the Background of Fulminant Lymphocytic-Macrophage Myocarditis]S V Mayrina, I A Makarov, K B Lapshin, et al.
Kardiologiia|February 22, 2018
[Interventional treatment in patients with myocarditis: Pro and Contra]V A Syrovnev, D S Lebedev, L B Mitrofanova, et al.
Pageof 6